Kala Bio (KALA) Revenue (2019 - 2022)
Kala Bio (KALA) posted Revenue of $420000.0 for Q3 2022, down 80.0% sequentially from $2.1 million in Q2 2022, and down 86.31% YoY from $3.1 million in Q3 2021.
Kala Bio (KALA) Revenue (2019 - 2022) Analysis & Trends
Kala Bio has reported Revenue for 4 years, with the latest figure at $420000.0 in Q3 2022.
- Quarterly Revenue fell 86.31% year-over-year to $420000.0 in Q3 2022, while the trailing twelve-month figure through Dec 2022 was $3.9 million (down 65.37% YoY) and the FY2022 annual result came in at $3.9 million, down 65.37% from the prior year.
- Revenue slipped to $420000.0 in Q3 2022 per KALA's latest filing, from $2.1 million in the prior quarter.
- Over five years, Revenue peaked at $3.3 million in Q1 2021 and troughed at $420000.0 in Q3 2022.
- A 4-year average of $1.8 million and a median of $1.9 million in 2021 frame the typical range for Revenue.
- The sharpest annual moves came in 2021 and 2022: Revenue jumped 266.27% in 2021, then plunged 86.31% in 2022.
- Over 4 years, Revenue stood at $1.2 million in 2019, then surged by 89.66% to $2.2 million in 2020, then dropped by 17.07% to $1.9 million in 2021, then tumbled by 77.37% to $420000.0 in 2022.
- According to Business Quant data, Revenue over the past three periods registered $420000.0, $2.1 million, and $1.4 million for Q3 2022, Q2 2022, and Q1 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.29 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 425.49 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 674.14 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.06 Bn |
| 10 | Kala Bio | 9.87 Mn | 9.87 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 420,000.00 |
| Jun 30, 2022 | 2.10 Mn |
| Mar 31, 2022 | 1.37 Mn |
| Dec 31, 2021 | 1.86 Mn |
| Sep 30, 2021 | 3.07 Mn |
| Jun 30, 2021 | 3.05 Mn |
| Mar 31, 2021 | 3.27 Mn |
| Dec 31, 2020 | 2.24 Mn |
| Sep 30, 2020 | 2.22 Mn |
| Jun 30, 2020 | 833,000.00 |
| Mar 31, 2020 | 1.07 Mn |
| Dec 31, 2019 | 1.18 Mn |
| Sep 30, 2019 | 1.45 Mn |
| Jun 30, 2019 | 2.06 Mn |
| Mar 31, 2019 | 1.39 Mn |